Liquid Biopsy Market is Projected to Reach USD 2,790.6 Million By 2026 : Top Companies, Trends And Future Prospects Details For Business Development

Global Liquid Biopsy Market Analysis

According to Verified Market Research, the Global Liquid Biopsy Market was valued at USD 691.6 Million in 2018 and is projected to reach USD 2,790.6 Million by 2026, growing at a CAGR of 19.42 % from 2019 to 2026.

A liquid biopsy is a non-invasive and simple alternative to the ‘traditional’ or surgical biopsies and involves the sampling and analysis of non-solid biological tissue, primarily blood. Liquid biopsies enable medical professionals to be able to discover several aspects concerning a tumor through a patient’s blood sample. The liquid biopsy facilitates medical professionals to understand which treatments are most likely to work for the patient. Liquid biopsies is a beneficial alternative to surgical biopsies in the case of patients whose tissue is unable to be biopsied or as an addition in order to comprehensively evaluate drug response. This method also allows for an accurate understanding of the genomic landscape of a tumor, by being able to avoid conventional issues such as intratumor heterogeneity.

Request For Free Sample Of The Report @https://www.verifiedmarketresearch.com/download-sample/?rid=3757&utm_source=OP&utm_medium=Ranu&utm_campaign=Ranu

Global Liquid Biopsy Market Overview

With the advent of technological advancement in the healthcare sector, areas of medicine such as the diagnosis and treatment through progressive technology and minimally invasive procedures have therefore grown significantly as a result. With non-invasive or minimally invasive methods in general, there are several advantages as compared to its counterpart as it involves the drastic increase in overall patient safety as well as leads to enhanced customer satisfaction through decreasing or eliminating the overall patient recovery time.

As per the above figure, it can be said that the global minimal surgery market will have doubled in size from 2012 to 2019. The growing economies of countries such as India and China whose substantial population itself demands an increase in healthcare. This is driving the increased potential for the growth of the liquid biopsy market.

Moreover, the increasing prevalence of cancer cases is playing a major role in the growth of the liquid biopsy market. The Americas is the major contributor in the liquid biopsy market partly due to the prevalence of cancer treatment and its research as well as the rising older population in the Americas. The rising older population is playing a key role in the increased adoption of liquid biopsy tests. On the other hand, the lack of skilled professionals and a lack of knowledge about liquid biopsy will pose a challenge to the growth of the market at a global level.

Ask For Discount : https://www.verifiedmarketresearch.com/download-sample/?rid=3757&utm_source=OP&utm_medium=Ranu&utm_campaign=Ranu

Global Liquid Biopsy Market: Segmentation

The Liquid Biopsy market is segmented on the basis of Product and Service, Circulating Biomarker, Cancer Type, End-User and geography. On the basis of Cancer type, the market is bifurcated into Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Liver Cancer, and Other Cancers.

liquid biopsy market by cancer type

Lung Cancer accounted for the largest market share of 35.34% in 2017 and is projected to grow at the highest CAGR during the forecast period. The frequencies of lung cancer have significantly increased over the last century mainly due to smoking and remain the most frequently diagnosed cancer and the leading cause of cancer-related mortality worldwide. Due to the limitation of tissue biopsy, lung cancer misdiagnoses, inadequate tumor sampling and delayed diagnoses are common factors of the leading deaths. The advent of liquid biopsy technology allows a better understanding of the tumor microenvironment and systematic actions of tumor and this may allow molecular diagnostic to be done on circulating tumor DNA.

On the basis of the regional analysis, the global liquid biopsy market is classified into North America, Europe, Asia Pacific and Rest of the world. North America dominated and accounted for 41.0% of the Liquid Biopsy Market in 2018. Growing old population in this region, with rising healthcare awareness is driving the market for liquid biopsy. Moreover, the increase in investment by leading market players and hospitals providers is expected to boost the market in the region.

The major players in the market are Biocept, Inc., Qiagen, F. Hoffmann-La Roche AG, Bio-Rad Laboratories Inc., Myriad Genetics, Janssen Diagnostics, LLC, Trovagene Inc., Guardant Health Inc., GRAIL, and MDX Health SA.

Obtain Report Details @ https://www.verifiedmarketresearch.com/download-sample/?rid=3757&utm_source=OP&utm_medium=Ranu&utm_campaign=Ranu

KEY DEVELOPMENTS

Roche Diagnostics - Product Launches :

. Roche launched NGS AVENIO Tumor Tissue Analysis Kits for oncology research

· The kits detected all four mutation classes in solid tumors, complement Roche’s NGS ctDNA kits for oncology research

Biocept, Inc. - Partnership and Agreements

· Biocept Entered into Agreement with Alliance Global FZ to Market

· This agreement resulted in Distribution of Liquid Biopsy Testing in the Middle East, Southeast Asia, and Africa Region

Thermo Fisher Scientific - Expansion

· Thermo Fisher Scientific Expanded Oncomine Portfolio for Liquid Biopsy and Immuno-oncology Clinical Research

About us-

Verified Market Research’ has been providing Research Reports, with up to date information, and in-depth analysis, for several years now, to individuals and companies alike that are looking for accurate Research Data. Our large database includes the latest Content from renowned authors and publications worldwide. We’ve recently developed a one of its own kind smart-system, which helps us determine the authenticity and reputation of the content and its author. This ‘smart-system’ ensures that we always include high – quality content in our database. We also provide customized Data and Reports according to the need of our client. We strive for excellence and perfection in all our work, and our in-house team is working 24/7 so that you get the Data, Reports, and Analytics you need to help make better decisions. We believe in Customer Satisfaction, and to achieve that we aim to understand the client’s need to provide ‘tailor-made’ services.

Our aim is to save your Time and Resources, providing you with the required Research Data, so you can only concentrate on Progress and Growth. Our Data includes research from various industries, along with all necessary statistics like Market Trends, or Forecasts from reliable sources.

Contact us -

New Jersey ( USA )
218 Washington Street,
Boonton 07005
Tel:+1 (800) 782 1768
sales@verifiedmarketresearch.com

This release was published on openPR.